Press Release – Panacea Pharma Projects Limited rebrands to PrimeVigilance

Isle of Man, 16 July 2024

PrimeVigilance, an Ergomed Group company, is delighted to share the exciting news that Panacea Pharma Projects Limited is rebranding to PrimeVigilance (‘PrimeVigilance Limited’).

In Q4 of 2023, we shared the news of Ergomed Group’s acquisition of Panacea Pharma Projects, a company that has consistently delivered bespoke pharmacovigilance, regulatory affairs, quality assurance, auditing, and support services to the pharmaceutical, biotech, and medical device sector since its inception in 2008.

With shared culture, service delivery standards, and a dedication to maintaining the highest quality and reputation, the integration of Panacea into PrimeVigilance is a natural fit. Together, we are poised to create a positive impact, uphold our commitment to excellence, and further strengthen our position as the global leader in pharmacovigilance.

 

Statement from Sally Amanuel, President of PrimeVigilance:

“Today marks a significant milestone in our journey as we proudly announce the successful integration of Panacea into the PrimeVigilance team and the rebranding of Panacea to PrimeVigilance. This accomplishment is a testament to the dedication and hard work of our teams, who have seamlessly blended their expertise and commitment to excellence.

Since the acquisition, Panacea has proven to be an invaluable asset, bringing their high-quality bespoke pharmacovigilance services for Generics and Biosimilar products into our fold. Their alignment with our market positioning and strategic goals has reinforced our industry standing and bolstered our ambition to capture the Asian market.

The integration has been a harmonious process, thanks to the shared culture, service delivery standards, and dedication to maintaining the highest quality and reputation. Rebranding Panacea as PrimeVigilance symbolizes our commitment to providing consistent and exceptional service under a single, trusted name.

We extend our heartfelt gratitude to the talented professionals from Panacea who have joined us on this exciting journey. Their expertise and dedication have been instrumental in this successful integration. We are excited about the future and the opportunities this integration and rebranding bring to our clients, partners, and the industry as a whole. Together, we are PrimeVigilance.”

 

About PrimeVigilance

PrimeVigilance, an Ergomed company, is the leading pharmacovigilance and medical information specialist service provider. We deliver global solutions for clinical safety, post-marketing and medical information in over 160+ countries.

We augment our domain expertise by integrating medical and scientific knowledge with regulatory science in clinical settings and in everyday practice. We identify previously unrecognized adverse effects or changes in their patterns to ascertain what action is necessary to optimize safe and effective use of medicines and medical devices. Our adaptable business models and integrative project management coupled with our flexibility as a partner, consistently fulfill our clients’ business requirements and safeguard their assets.

Our global footprint, continuous investment in automated technology and resources as well as our product expertise render us the partner of choice for more than 350+ clients.

 

For further information, visit https://primevigilance.com/